GSK3B and Alzheimer disease: When we treated SH-SY5Y cells with an inhibitor of GSK-3β, methionine deficiency or excess no longer altered Aβ and p-Tau levels, demonstrating that GSK-3β is a key downstream protein in methionine-regulated AD (Figure 4D).